Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$0.28 - $1.16 $41,545 - $172,116
-148,376 Reduced 38.84%
233,644 $77,000
Q1 2024

Apr 25, 2024

BUY
$1.06 - $1.67 $111,395 - $175,500
105,090 Added 37.95%
382,020 $443,000
Q4 2023

Feb 02, 2024

BUY
$1.26 - $1.79 $187,813 - $266,813
149,058 Added 116.57%
276,930 $468,000
Q3 2023

Nov 01, 2023

SELL
$1.61 - $2.54 $214,973 - $339,150
-133,524 Reduced 51.08%
127,872 $231,000
Q2 2023

Aug 04, 2023

BUY
$1.14 - $1.95 $293,770 - $502,501
257,693 Added 6959.03%
261,396 $486,000
Q1 2023

Apr 27, 2023

BUY
$1.2 - $2.19 $4,023 - $7,343
3,353 Added 958.0%
3,703 $4,000
Q4 2022

Feb 02, 2023

BUY
$1.63 - $3.52 $163 - $352
100 Added 40.0%
350 $0
Q3 2022

Nov 04, 2022

SELL
$0.73 - $3.74 $35,912 - $183,989
-49,195 Reduced 99.49%
250 $0
Q2 2022

Aug 03, 2022

SELL
$2.2 - $4.2 $431,963 - $824,657
-196,347 Reduced 79.88%
49,445 $117,000
Q1 2022

May 02, 2022

BUY
$2.83 - $8.69 $695,591 - $2.14 Million
245,792 New
245,792 $990,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $19B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.